Covid-19 vaccine for children under six seeking approval


By AGENCY
While protection against SARS-CoV-2 infection is not that good, the Moderna Covid-19 vaccine does strongly prevent young children from having severe disease, being hospitalised and dying from the disease. — AFP

American biotech firm Moderna is pursuing regulatory approval for its Covid-19 vaccine in children under six years of age after the two-shot regimen was found to be safe and produced a strong immune response, the company said on Mac 23 (2022).

Specifically, two doses of 25mcg given to babies, toddlers and preschoolers, generated similar levels of antibodies to two doses of 100mcg given to young people aged 18-25, indicating that there would be similar levels of protection.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Health

Faking symptoms to get antibiotics
Premature babies: Their fight to survive�
Diabetic retinopathy: When diabetes steals your sight
Plant proteins can help boost testosterone
How industry players influence government regulators�
When your brain won't let you fall sleep
Dispensing drugs to the disabled
One in four teens not getting enough physical activity
For babies, it's back to sleep, tummy to play�
Circadian depression:�When body clock disruptions affect the mind

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read